What are the recommended acute and preventive medications for treating migraines in adults without contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Migraine Medications: Acute and Preventive Treatment

Acute Treatment

Start with an NSAID (ibuprofen, naproxen, diclofenac, aspirin, or celecoxib) or acetaminophen at adequate doses; if insufficient pain relief occurs, add a triptan to the NSAID (or to acetaminophen if NSAIDs are contraindicated). 1

Stepwise Approach to Acute Treatment

For Mild Episodic Migraine:

  • Use NSAID monotherapy, acetaminophen, or their combination 1
  • Ensure adequate dosing before escalating therapy

For Moderate to Severe Episodic Migraine:

  1. First-line: Combination therapy - Triptan + NSAID provides the greatest net benefit (moderate-certainty evidence) 1

    • Specific triptans: almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan
    • Specific NSAIDs: aspirin, celecoxib, diclofenac, ibuprofen, or naproxen
    • Alternative: Triptan + acetaminophen (when NSAIDs contraindicated) 1
  2. Second-line options (if combination therapy fails or is not tolerated):

    • CGRP antagonists-gepants: rimegepant, ubrogepant, or zavegepant 1
    • Dihydroergotamine (ergot alkaloid) 1
  3. Third-line option:

    • Lasmiditan (ditan) - reserve for patients who fail all other treatments 1

Critical Contraindications:

  • Never use opioids or butalbital for acute episodic migraine 1

Special Situations

Severe nausea/vomiting:

  • Use nonoral triptan formulations (nasal spray, subcutaneous injection) plus antiemetic 1

Treatment timing:

  • Begin treatment as soon as possible after migraine onset 1
  • Early treatment with combination therapy improves efficacy

Preventive Treatment

For episodic migraine prevention, initiate monotherapy with propranolol (beta-blocker), topiramate (antiseizure medication), or amitriptyline (tricyclic antidepressant) as first-line options. 2

First-Line Preventive Medications (Episodic Migraine)

Traditional oral agents:

  • Beta-blockers: Propranolol or metoprolol 3, 4
  • Antiseizure medications: Topiramate (reduces migraine days by 1.4/month vs placebo) or valproate 3, 4
  • Tricyclic antidepressants: Amitriptyline (reduces migraine days by 1.2/month vs placebo) 4
  • Calcium channel blockers: Flunarizine 3

Newer CGRP-targeted therapies (considered first-line by some guidelines, second-line by others based on cost/access):

  • Monoclonal antibodies: Eptinezumab, erenumab, fremanezumab, galcanezumab (reduce migraine days by 0.7-3.8/month) 5, 4
  • Oral gepants: Atogepant or rimegepant (reduce migraine days by 0.7-2.4/month) 5, 4

Chronic Migraine Prevention

First-line options:

  • Topiramate 3
  • Flunarizine 3
  • OnabotulinumtoxinA (after failure of multiple oral preventives) 3
  • CGRP monoclonal antibodies 3, 4

Indications to Start Preventive Treatment

Initiate prevention when:

  • Headache frequency ≥4 days per month 3
  • Profound disability from attacks
  • Failure of or contraindication to acute therapies
  • Complicated migraine with debilitating auras
  • Migrainous brain infarction 3

Treatment Principles

Dosing strategy for oral medications:

  • "Start low and go slow" 3
  • Titrate to therapeutic dose if tolerated
  • Allow adequate trial duration (typically 2-3 months)

Duration of preventive therapy:

  • Episodic migraine: Consider tapering after 3-6 months of sustained improvement 3
  • Chronic migraine: Consider tapering after 6-12 months of sustained improvement 3

If initial preventive fails:

  • Try another medication within the same class (patients may respond differently) 1
  • Consider CGRP-targeted therapies if traditional oral agents fail 4

Critical Warnings

Medication Overuse Headache

  • Occurs with ≥15 days/month of NSAID or acetaminophen use 1
  • Occurs with ≥10 days/month of triptan use 1
  • Defined as headache on ≥15 days/month for ≥3 months due to acute medication overuse
  • Education about not overusing acute medications is essential 3

Pregnancy and Lactation

  • Discuss adverse effects of all pharmacologic treatments with people of childbearing potential 1
  • Most migraine medications have limited safety data in pregnancy
  • Treatment decisions require careful risk-benefit analysis

Cost Considerations

  • Prescribe less costly recommended medications when appropriate 1
  • CGRP-targeted therapies are significantly more expensive than traditional oral preventives
  • Patient preference data shows cost is a major factor in treatment decisions 1

Lifestyle Modifications (Essential Adjunct)

Counsel all patients on:

  • Adequate hydration
  • Regular meals
  • Sufficient and consistent sleep
  • Regular moderate-to-intense aerobic exercise
  • Stress management (relaxation techniques, mindfulness)
  • Weight loss if overweight/obese
  • Identify and modify personal migraine triggers 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.